HemaX Genome is involved in the identification of genes of medical interest on chromosome X.

History:

HemaX Genome was acquired by Emerillon Therapeutics in 2005.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
North America

Research Focus:
Genomics

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: